Blogs
on April 23, 2024
IMARC Group, a leading market research company, has recently releases report titled “Anti-Obesity Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032”, Offers a comprehensive analysis of the industry, which comprises insights on the market.
How Big is the Anti-Obesity Drugs Market?
The global anti-obesity drugs market size reached US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 10.3% during 2024-2032.
Industry Overview of Anti-Obesity Drugs
Anti-obesity drugs, also known as weight-loss medications, are prescribed as a part of a comprehensive weight-loss program that includes lifestyle modifications, such as dietary changes and increased physical activities. They are intended for individuals with a body mass index (BMI) above a certain threshold or those with obesity-related health conditions. They are typically prescribed under the supervision of healthcare professionals and are not intended for cosmetic weight loss purposes. As they assist in reducing feelings of hunger, promoting satiety, absorbing fat, and increasing metabolism, the demand for anti-obesity drugs is increasing around the world.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/anti-obesity-drugs-market/requestsample
What are the growth prospects and trends in the anti-obesity drugs industry?
At present, the growing rate of obesity among the masses due to changing lifestyles and decreasing exercise practices represents one of the major key factors influencing the market positively.
In addition, the rising awareness about healthy lifestyles among individuals is providing lucrative growth opportunities to industry investors. Besides this, key players are investing in research and development (R&D) activities to introduce drugs that can counter both obesity and type 2 diabetes. Moreover, the rising intake of junk food and fast food products among youngsters is propelling the growth of the market.
Apart from this, the increasing number of approvals of anti-obesity medications (AOMs) that help regulate appetite and food cravings is strengthening the growth of the market.
Leading Companies Operating in the Global Anti-Obesity Drugs Industry:
- Boehringer Ingelheim International GmbH
- Currax Pharmaceuticals LLC
- Gelesis
- GlaxoSmithKline plc
- Merck & Co. Inc.
- Norgine B.V.
- Novo Nordisk A/S
- Pfizer Inc.
- Rhythm Pharmaceuticals Inc.
- SHIONOGI & Co. Ltd.
- Takeda Pharmaceutical Company Limited
- Vivus LLC.
Anti-Obesity Drugs Market Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Drug Class:
- Peripherally Acting Drugs
- Centrally Acting Drugs
Breakup by Drug Type:
- Prescription Drugs
- OTC Drugs
Breakup by Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
Posted in: Health
Topics:
anti-obesity drugs market